CoChat

Postprandial Hyperlipidemia and Remnant Lipoproteins

Open access
Masuda, Daisaku, Yamashita, Shizuya · 2017 · Journal of Atherosclerosis and Thrombosis

The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.

Abstract

Fasting hypertriglyceridemia is positively associated with the morbidity of coronary heart disease (CHD), and postprandial (non-fasting) hypertriglyceridemia is also correlated with the risk status for CHD, which is related to the increase in chylomicron (CM) remnant lipoproteins produced from the intestine. CM remnant particles, as well as oxidized low density lipoprotein (LDL) or very low density lipoprotein (VLDL) remnants, are highly atherogenic and act by enhancing systemic inflammation, platelet activation, coagulation, thrombus formation, and macrophage foam cell formation. The cholesterol levels of remnant lipoproteins significantly correlate with small, dense LDL; impaired glucose tolerance (IGT) and CHD prevalence. We have developed an assay of apolipoprotein (apo)B-48 levels to evaluate the accumulation of CM remnants. Fasting apoB-48 levels correlate with the morbidity of postprandial hypertriglyceridemia, obesity, type III hyperlipoproteinemia, the metabolic syndrome, hypothyroidism, chronic kidney disease, and IGT. Fasting apoB-48 levels also correlate with carotid intima-media thickening and CHD prevalence, and a high apoB-48 level is a significant predictor of CHD risk, independent of the fasting TG level. Diet interventions, such as dietary fibers, polyphenols, medium-chain fatty acids, diacylglycerol, and long-chain n-3 polyunsaturated fatty acids (PUFA), ameliorate postprandial hypertriglyceridemia, moreover, drugs for dyslipidemia (n-3 PUFA, statins, fibrates or ezetimibe) and diabetes concerning incretins (dipeptidyl-peptidase IV inhibitor or glucagon like peptide-1 analogue) may improve postprandial hypertriglyceridemia. Since the accumulation of CM remnants correlates to impaired lipid and glucose metabolism and atherosclerotic cardiovascular events, further studies are required to investigate the characteristics, physiological activities, and functions of CM remnants for the development of new interventions to reduce atherogenicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5551/jat.rv16003

Cites

133 of 133 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1. Chylomicron remnants are accumulated in many metabolic disorders and contributes to the progression of atherosclerotic plaque Many metabolic disorders that correlate the hypertriglyceridemia, postprandial hypertriglyceridemia, type III hyperlipidemia, the metabolic syndrome, diabetes mellitus, impaired glucose tolerance, chronic kidney disease, are related to the accumulation of chylomicron remnants and high apolipoprotein(apo)B-48 concentrations. Chylomicron remnants in sera can directly penetrate into the arterial wall and infiltrate the sub-endothelial space. They enhance systemic inflammation, induce platelet activation, the proliferation of smooth muscle cells, the adhesion of the monocyte, apoptosis of endothelial cells and macrophage foam cell formation. These changes induce the instability and progression of atherosclerotic plaque. High apoB-48 concentrations correlate with the thickening of carotid arteries and the prevalence of coronary artery stenosis.
Fig. 1. Chylomicron remnants are accumulated in many metabolic disorders and contributes to the progression of atherosclerotic plaque Many metabolic disorders that correlate the hypertriglyceridemia, postprandial hypertriglyceridemia, type III hyperlipidemia, the metabolic syndrome, diabetes mellitus, impaired glucose tolerance, chronic kidney disease, are related to the accumulation of chylomicron remnants and high apolipoprotein(apo)B-48 concentrations. Chylomicron remnants in sera can directly penetrate into the arterial wall and infiltrate the sub-endothelial space. They enhance systemic inflammation, induce platelet activation, the proliferation of smooth muscle cells, the adhesion of the monocyte, apoptosis of endothelial cells and macrophage foam cell formation. These changes induce the instability and progression of atherosclerotic plaque. High apoB-48 concentrations correlate with the thickening of carotid arteries and the prevalence of coronary artery stenosis.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 133 references

Cited by

See all 145

Metadata

Authors
Masuda, D., & Yamashita, S.
Affiliations
  • The University of Osaka (JP)
  • Rinku General Medical Center (JP)
Corresponding author
Masuda, Daisaku
Venue
Journal of Atherosclerosis and Thrombosis
Published
2017
Volume
24
Issue
2
Pages
95-109
ISSN
  • 1340-3478 (ISSN-L)
  • 1880-3873
OpenAlex
W2554722168
Cited by
145
References
133
Citations by year
2026: 9 · 2025: 6 · 2024: 13 · 2023: 17 · 2022: 19 · 2021: 21 · 2020: 18 · 2019: 18 · 2018: 14 · 2017: 8
FWCI
2.32
Type
journal article
Language
en
Open access
Licence
cc-by-nc-sa
Locations
  • Journal of Atherosclerosis and Thrombosis (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
Funders
  • Boehringer Ingelheim Japan
  • Ono Pharmaceutical
  • MSD K.K.
  • Japan Society for the Promotion of Science (17H02100, 15K01713)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
postprandial hypertriglyceridemia, chylomicron remnants, remnant lipoproteins, apolipoprotein B-48, coronary heart disease risk, atherosclerosis, small dense LDL, impaired glucose tolerance, type III hyperlipoproteinemia, metabolic syndrome, carotid intima-media thickening, dietary fiber, polyphenols, medium-chain fatty acids, diacylglycerol, omega-3 fatty acids, statins, fibrates, ezetimibe, incretins, dyslipidemia
MeSH terms
Animals, Cholesterol, Humans, Hyperlipidemias, Lipoproteins, Triglycerides, Postprandial Period

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Postprandial Hyperlipidemia and Remnant Lipoproteins. https://app.cochat.ai/papers/10.5551/jat.rv16003
The paper
Masuda, D., & Yamashita, S. (2017). Postprandial Hyperlipidemia and Remnant Lipoproteins. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv16003

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.